MLTX

MoonLake Immunotherapeutics

Phase 3 AI-extracted

sonelokimab

hidradenitis suppurativa

Resolved

16days ago

Phase 3 readout · Jun 21, 2026

What's at stake Phase 3 trial results for sonelokimab in hidradenitis suppurativa are due Jun 21, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 15h ago

“MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa.”

Add to calendar Post on X Reddit

Provenance